{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T20:42:45Z","timestamp":1790887365145,"version":"4.1.0"},"reference-count":40,"publisher":"American Medical Association (AMA)","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"abstract":"<jats:sec id=\"ab-zoi231038-4\"><jats:title>Importance<\/jats:title><jats:p>Untreated depression is a growing public health concern, with patients often facing a prolonged trial-and-error process in search of effective treatment. Developing a predictive model for treatment response in clinical practice remains challenging.<\/jats:p><\/jats:sec><jats:sec id=\"ab-zoi231038-5\"><jats:title>Objective<\/jats:title><jats:p>To establish a model based on electroencephalography (EEG) to predict response to 2 distinct selective serotonin reuptake inhibitor (SSRI) medications.<\/jats:p><\/jats:sec><jats:sec id=\"ab-zoi231038-6\"><jats:title>Design, Setting, and Participants<\/jats:title><jats:p>This prognostic study developed a predictive model using EEG data collected between 2011 and 2017 from 2 independent cohorts of participants with depression: 1 from the first Canadian Biomarker Integration Network in Depression (CAN-BIND) group and the other from the Establishing Moderators and Biosignatures of Antidepressant Response for Clinical Care (EMBARC) consortium. Eligible participants included those aged 18 to 65 years who had a diagnosis of major depressive disorder. Data were analyzed from January to December 2022.<\/jats:p><\/jats:sec><jats:sec id=\"ab-zoi231038-7\"><jats:title>Exposures<\/jats:title><jats:p>In an open-label trial, CAN-BIND participants received an 8-week treatment regimen of escitalopram treatment (10-20 mg), and EMBARC participants were randomized in a double-blind trial to receive an 8-week sertraline (50-200 mg) treatment or placebo treatment.<\/jats:p><\/jats:sec><jats:sec id=\"ab-zoi231038-8\"><jats:title>Main Outcomes and Measures<\/jats:title><jats:p>The model\u2019s performance was estimated using balanced accuracy, specificity, and sensitivity metrics. The model used data from the CAN-BIND cohort for internal validation, and data from the treatment group of the EMBARC cohort for external validation. At week 8, response to treatment was defined as a 50% or greater reduction in the primary, clinician-rated scale of depression severity.<\/jats:p><\/jats:sec><jats:sec id=\"ab-zoi231038-9\"><jats:title>Results<\/jats:title><jats:p>The CAN-BIND cohort included 125 participants (mean [SD] age, 36.4 [13.0] years; 78 [62.4%] women), and the EMBARC sertraline treatment group included 105 participants (mean [SD] age, 38.4 [13.8] years; 72 [68.6%] women). The model achieved a balanced accuracy of 64.2% (95% CI, 55.8%-72.6%), sensitivity of 66.1% (95% CI, 53.7%-78.5%), and specificity of 62.3% (95% CI, 50.1%-73.8%) during internal validation with CAN-BIND. During external validation with EMBARC, the model achieved a balanced accuracy of 63.7% (95% CI, 54.5%-72.8%), sensitivity of 58.8% (95% CI, 45.3%-72.3%), and specificity of 68.5% (95% CI, 56.1%-80.9%). Additionally, the balanced accuracy for the EMBARC placebo group (118 participants) was 48.7% (95% CI, 39.3%-58.0%), the sensitivity was 50.0% (95% CI, 35.2%-64.8%), and the specificity was 47.3% (95% CI, 35.9%-58.7%), suggesting the model\u2019s specificity in predicting SSRIs treatment response.<\/jats:p><\/jats:sec><jats:sec id=\"ab-zoi231038-10\"><jats:title>Conclusions and Relevance<\/jats:title><jats:p>In this prognostic study, an EEG-based model was developed and validated in 2 independent cohorts. The model showed promising accuracy in predicting treatment response to 2 distinct SSRIs, suggesting potential applications for personalized depression treatment.<\/jats:p><\/jats:sec>","DOI":"10.1001\/jamanetworkopen.2023.36094","type":"journal-article","created":{"date-parts":[[2023,9,28]],"date-time":"2023-09-28T15:37:41Z","timestamp":1695915461000},"page":"e2336094","source":"Crossref","is-referenced-by-count":24,"title":["Developing an Electroencephalography-Based Model for Predicting Response to Antidepressant Medication"],"prefix":"10.1001","volume":"6","author":[{"given":"Benjamin","family":"Schwartzmann","sequence":"first","affiliation":[{"name":"eBrain Lab, School of Mechatronic Systems Engineering, Simon Fraser University, Surrey, British Columbia, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prabhjot","family":"Dhami","sequence":"additional","affiliation":[{"name":"eBrain Lab, School of Mechatronic Systems Engineering, Simon Fraser University, Surrey, British Columbia, Canada"},{"name":"Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada"},{"name":"Centre for Addiction and Mental Health, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rudolf","family":"Uher","sequence":"additional","affiliation":[{"name":"Department of Psyciatry, Dalhousie University, Halifax, Nova Scotia, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raymond W.","family":"Lam","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, University of British Columbia, Vancouver, British Columbia, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benicio N.","family":"Frey","sequence":"additional","affiliation":[{"name":"Department of Psychiatry and Behavioural Neurosciences, McMaster University, Hamilton, Ontario, Canada"},{"name":"Mood Disorders Program and Women\u2019s Health Concerns Clinic, St. Joseph\u2019s Healthcare, Hamilton, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roumen","family":"Milev","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, Queen\u2019s University, Providence Care, Kingston, Ontario, Canada"},{"name":"Department of Psychology, Queen\u2019s University, Providence Care, Kingston, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel J.","family":"M\u00fcller","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada"},{"name":"Centre for Addiction and Mental Health, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Blier","sequence":"additional","affiliation":[{"name":"Mood Disorders Research Unit, University of Ottawa Institute of Mental Health Research, Ottawa, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudio N.","family":"Soares","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, Queen\u2019s University, Providence Care, Kingston, Ontario, Canada"},{"name":"Department of Psychology, Queen\u2019s University, Providence Care, Kingston, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sagar V.","family":"Parikh","sequence":"additional","affiliation":[{"name":"University of Michigan Depression Center, Ann Arbor"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gustavo","family":"Turecki","sequence":"additional","affiliation":[{"name":"Douglas Mental Health University Institute, Department of Psychiatry, McGill University, Montreal, Quebec, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jane A.","family":"Foster","sequence":"additional","affiliation":[{"name":"Department of Psychiatry and Behavioural Neurosciences, McMaster University, Hamilton, Ontario, Canada"},{"name":"Center for Depression Research and Clinical Care, University of Texas Southwestern Medical Center, Dallas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"Rotzinger","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada"},{"name":"Mood Disorders Program and Women\u2019s Health Concerns Clinic, St. Joseph\u2019s Healthcare, Hamilton, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sidney H.","family":"Kennedy","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada"},{"name":"Unity Health Toronto, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faranak","family":"Farzan","sequence":"additional","affiliation":[{"name":"eBrain Lab, School of Mechatronic Systems Engineering, Simon Fraser University, Surrey, British Columbia, Canada"},{"name":"Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada"},{"name":"Centre for Addiction and Mental Health, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2023,9,28]]},"reference":[{"issue":"11","key":"zoi231038r2","doi-asserted-by":"publisher","first-page":"1905","DOI":"10.1176\/ajp.2006.163.11.1905","article-title":"Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report.","volume":"163","author":"Rush","year":"2006","journal-title":"Am J Psychiatry"},{"issue":"1","key":"zoi231038r3","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1176\/appi.ajp.163.1.28","article-title":"Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice.","volume":"163","author":"Trivedi","year":"2006","journal-title":"Am J Psychiatry"},{"issue":"11","key":"zoi231038r4","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1016\/j.euroneuro.2009.06.001","article-title":"Frontal EEG predictors of treatment outcome in major depressive disorder.","volume":"19","author":"Iosifescu","year":"2009","journal-title":"Eur Neuropsychopharmacol"},{"issue":"7","key":"zoi231038r5","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1016\/j.clinph.2009.05.008","article-title":"Rostral anterior cingulate cortex theta current density and response to antidepressants and placebo in major depression.","volume":"120","author":"Korb","year":"2009","journal-title":"Clin Neurophysiol"},{"key":"zoi231038r6","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1016\/j.jad.2017.10.028","article-title":"The comparative effectiveness of electroencephalographic indices in predicting response to escitalopram therapy in depression: a pilot study.","volume":"227","author":"Baskaran","year":"2018","journal-title":"J Affect Disord"},{"issue":"12","key":"zoi231038r7","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1016\/j.biopsych.2007.10.009","article-title":"Electroencephalographic alpha measures predict therapeutic response to a selective serotonin reuptake inhibitor antidepressant: pre- and post-treatment findings.","volume":"63","author":"Bruder","year":"2008","journal-title":"Biol Psychiatry"},{"issue":"6","key":"zoi231038r8","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1055\/s-2000-8356","article-title":"Pre-treatment EEG and its relationship to depression severity and paroxetine treatment outcome.","volume":"33","author":"Knott","year":"2000","journal-title":"Pharmacopsychiatry"},{"issue":"1-3","key":"zoi231038r9","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/S0165-0327(01)00308-1","article-title":"EEG correlates of acute and chronic paroxetine treatment in depression.","volume":"69","author":"Knott","year":"2002","journal-title":"J Affect Disord"},{"issue":"6","key":"zoi231038r10","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1177\/0269881114523862","article-title":"Examining relations between alpha power as well as anterior cingulate cortex-localized theta activity and response to single or dual antidepressant pharmacotherapies.","volume":"28","author":"Jaworska","year":"2014","journal-title":"J Psychopharmacol"},{"issue":"1","key":"zoi231038r11","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1176\/appi.ajp.2018.17121358","article-title":"Electroencephalographic biomarkers for treatment response prediction in major depressive illness: a meta-analysis.","volume":"176","author":"Widge","year":"2019","journal-title":"Am J Psychiatry"},{"issue":"6","key":"zoi231038r12","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2020.7133","article-title":"Are electroencephalogram-derived predictors of antidepressant efficacy closer to clinical usefulness?","volume":"3","author":"Iosifescu","year":"2020","journal-title":"JAMA Netw Open"},{"issue":"1","key":"zoi231038r13","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2019.18377","article-title":"Use of machine learning for predicting escitalopram treatment outcome from electroencephalography recordings in adult patients with depression.","volume":"3","author":"Zhdanov","year":"2020","journal-title":"JAMA Netw Open"},{"issue":"4","key":"zoi231038r14","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1038\/s41587-019-0397-3","article-title":"An electroencephalographic signature predicts antidepressant response in major depression.","volume":"38","author":"Wu","year":"2020","journal-title":"Nat Biotechnol"},{"issue":"6","key":"zoi231038r15","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2020.6653","article-title":"Evaluation of a machine learning model based on pretreatment symptoms and electroencephalographic features to predict outcomes of antidepressant treatment in adults with depression: a prespecified secondary analysis of a randomized clinical trial.","volume":"3","author":"Rajpurkar","year":"2020","journal-title":"JAMA Netw Open"},{"issue":"11","key":"zoi231038r16","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0224365","article-title":"Machine learning algorithm validation with a limited sample size.","volume":"14","author":"Vabalas","year":"2019","journal-title":"PLoS One"},{"issue":"3","key":"zoi231038r17","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1148\/radiol.2017171920","article-title":"Methodologic guide for evaluating clinical performance and effect of artificial intelligence technology for medical diagnosis and prediction.","volume":"286","author":"Park","year":"2018","journal-title":"Radiology"},{"issue":"16","key":"zoi231038r18","doi-asserted-by":"publisher","first-page":"2742","DOI":"10.1017\/S0033291721003871","article-title":"Machine learning in the prediction of depression treatment outcomes: a systematic review and meta-analysis.","volume":"51","author":"Sajjadian","year":"2021","journal-title":"Psychol Med"},{"issue":"2","key":"zoi231038r19","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.18m12202","article-title":"Symptomatic and functional outcomes and early prediction of response to escitalopram monotherapy and sequential adjunctive aripiprazole therapy in patients with major depressive disorder: a CAN-BIND-1 report.","volume":"80","author":"Kennedy","year":"2019","journal-title":"J Clin Psychiatry"},{"issue":"1","key":"zoi231038r20","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1186\/s12888-016-0785-x","article-title":"Discovering biomarkers for antidepressant response: protocol from the canadian biomarker integration network in depression (CAN-BIND) and clinical characteristics of the first patient cohort.","volume":"16","author":"Lam","year":"2016","journal-title":"BMC Psychiatry"},{"key":"zoi231038r21","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.jpsychires.2016.03.001","article-title":"Establishing moderators and biosignatures of antidepressant response in clinical care (EMBARC): rationale and design.","volume":"78","author":"Trivedi","year":"2016","journal-title":"J Psychiatr Res"},{"issue":"1","key":"zoi231038r22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12916-014-0241-z","article-title":"Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): the TRIPOD Statement.","volume":"13","author":"Collins","year":"2015","journal-title":"BMC Med"},{"issue":"20","key":"zoi231038r23","doi-asserted-by":"publisher","first-page":"2191","DOI":"10.1001\/jama.2013.281053","article-title":"World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects.","volume":"310","author":"World Medical Association","year":"2013","journal-title":"JAMA"},{"issue":"2 Pt 1","key":"zoi231038r24","doi-asserted-by":"publisher","DOI":"10.1103\/PhysRevE.71.021906","article-title":"Multiscale entropy analysis of biological signals.","volume":"71","author":"Costa","year":"2005","journal-title":"Phys Rev E Stat Nonlin Soft Matter Phys"},{"issue":"4","key":"zoi231038r25","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1093\/brain\/awx030","article-title":"Brain temporal complexity in explaining the therapeutic and cognitive effects of seizure therapy.","volume":"140","author":"Farzan","year":"2017","journal-title":"Brain"},{"issue":"May","key":"zoi231038r27","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.jad.2019.05.070","article-title":"Prediction of rTMS treatment response in major depressive disorder using machine learning techniques and nonlinear features of EEG signal.","volume":"256","author":"Hasanzadeh","year":"2019","journal-title":"J Affect Disord"},{"issue":"1","key":"zoi231038r28","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.bbe.2021.12.005","article-title":"Automated diagnosis of depression from EEG signals using traditional and deep learning approaches: a comparative analysis.","volume":"42","author":"Khosla","year":"2022","journal-title":"Biocybern Biomed Eng"},{"key":"zoi231038r29","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.inffus.2020.01.008","article-title":"Feature-level fusion approaches based on multimodal EEG data for depression recognition.","volume":"59","author":"Cai","year":"2020","journal-title":"Inf Fusion"},{"issue":"9","key":"zoi231038r30","doi-asserted-by":"publisher","first-page":"2839","DOI":"10.1016\/j.patcog.2015.03.009","article-title":"Performance evaluation of classification algorithms by k-fold and leave-one-out cross validation.","volume":"48","author":"Wong","year":"2015","journal-title":"Pattern Recognit"},{"issue":"Pt A","key":"zoi231038r31","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.neuroimage.2017.06.061","article-title":"Cross-validation failure: small sample sizes lead to large error bars.","volume":"180","author":"Varoquaux","year":"2018","journal-title":"Neuroimage"},{"issue":"2","key":"zoi231038r32","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1017\/S0033291707001730","article-title":"Measuring depression: comparison and integration of three scales in the GENDEP study.","volume":"38","author":"Uher","year":"2008","journal-title":"Psychol Med"},{"key":"zoi231038r33","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1016\/j.jad.2017.09.042","article-title":"Translating the HAM-D into the MADRS and vice versa with equipercentile linking.","volume":"226","author":"Leucht","year":"2018","journal-title":"J Affect Disord"},{"issue":"JAN","key":"zoi231038r34","doi-asserted-by":"publisher","first-page":"768","DOI":"10.3389\/fpsyt.2018.00768","article-title":"Leveraging machine learning approaches for predicting antidepressant treatment response using electroencephalography (EEG) and clinical data.","volume":"9","author":"Jaworska","year":"2019","journal-title":"Front Psychiatry"},{"issue":"10","key":"zoi231038r35","doi-asserted-by":"publisher","first-page":"1975","DOI":"10.1016\/j.clinph.2013.04.010","article-title":"A machine learning approach using EEG data to predict response to SSRI treatment for major depressive disorder.","volume":"124","author":"Khodayari-Rostamabad","year":"2013","journal-title":"Clin Neurophysiol"},{"issue":"2","key":"zoi231038r36","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0171409","article-title":"A wavelet-based technique to predict treatment outcome for major depressive disorder.","volume":"12","author":"Mumtaz","year":"2017","journal-title":"PLoS One"},{"issue":"1","key":"zoi231038r37","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1017\/S0033291714000129","article-title":"What is the impact of mental health-related stigma on help-seeking? a systematic review of quantitative and qualitative studies.","volume":"45","author":"Clement","year":"2015","journal-title":"Psychol Med"},{"issue":"11","key":"zoi231038r38","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.1016\/j.jpsychires.2012.08.003","article-title":"a Power, a asymmetry and anterior cingulate cortex activity in depressed males and females.","volume":"46","author":"Jaworska","year":"2012","journal-title":"J Psychiatr Res"},{"issue":"1","key":"zoi231038r39","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1016\/j.clinph.2015.05.032","article-title":"EEG alpha asymmetry as a gender-specific predictor of outcome to acute treatment with different antidepressant medications in the randomized iSPOT-D study.","volume":"127","author":"Arns","year":"2016","journal-title":"Clin Neurophysiol"},{"key":"zoi231038r40","doi-asserted-by":"publisher","DOI":"10.1017\/S0033291722002124","article-title":"Prediction of depression treatment outcome from multimodal data: a CAN-BIND-1 report.","author":"Sajjadian","year":"2022","journal-title":"Psychol Med"},{"key":"zoi231038r26","first-page":"555","volume-title":"ECCE2019: Proceedings of the 5th International Conference on Electrical, Control & Computer Engineering, Kuantan, Pahang, Malaysia, 29th July 2019","author":"Sha\u2019abani","year":"2020"},{"key":"zoi231038r1","unstructured":"World Health Organization. Depressive disorder (depression). March 31, 2023. Accessed August 25, 2023. https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/depression"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2809952\/schwartzmann_2023_oi_231038_1695236330.50259.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,28]],"date-time":"2023-09-28T15:37:45Z","timestamp":1695915465000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2809952"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,28]]},"references-count":40,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2023,9,5]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2023.36094","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,28]]}}}